WillisHollowayJr.MD

Psychiatry • Oklahoma City, OK

Child & Adolescent Psychiatry

Physician

Join to view full profile

Dr. Holloway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Holloway's full profile

Already have an account?

Office
6613 N Meridian Ave
Oklahoma City, OK 73116
Phone+1 405-603-8450

Fax+1 405-603-8455
Is this information wrong?

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Child and Adolescent Psychiatry, 1987 - 1989
University of Oklahoma Health Sciences CenterResidency, Psychiatry, 1985 - 1987
University of Oklahoma College of MedicineInternship, Transitional Year, 1984 - 1985
University of Oklahoma College of MedicineClass of 1984

Certifications & Licensure

OK State Medical License 1985 - 2024
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Start of enrollment: 2013 Nov 01
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Dasotraline SEP360-105 Pediatric PK/PD Study Start of enrollment: 2014 Jul 01
Completed
Phase 1
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Join now to see all

Press Mentions

Oklahomans Suffering from Chronic Pain, Depression Turning to New TreatmentOctober 16th, 2019

Hospital Affiliations

SSM Health St. Anthony Hospital - Oklahoma CityOklahoma City, Oklahoma
Oakwood SpringsOklahoma City, Oklahoma
SSM Health St. Anthony Hospital - MidwestOklahoma City, Oklahoma